Estimation of the excess mortality in chronic diseases from prevalence and incidence data
Aggregated health data such as claims data from health insurances become more and more available for research purposes. Estimates of excess mortality from prevalence and incidence of a chronic condition have only been possible for ages 50 years and older and have shown to be unstable in younger ages. The aim of this article is to explore the reasons why estimates of excess mortality for younger ages are prone to bias and what can be done to extend the age range to ages below 50 years.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
New ways of estimating excess mortality of chronic diseases: Insights from the illness-death model
Recently, we have shown that the age-specific prevalence of a disease can be related to the transition rates in the illness-death model via a partial differential equation (PDE). In case of a chronic disease, we show tha…
Contrastive Deep Learning Reveals Age Biomarkers in Histopathological Skin Biopsies
As global life expectancy increases, so does the burden of chronic diseases, yet individuals exhibit considerable variability in the rate at which they age. Identifying biomarkers that distinguish fast from slow ageing i…
Deep LearningHow to assess case-finding in chronic diseases: Comparison of different indices
Recently, we have proposed a new illness-death model that comprises a state of undiagnosed chronic disease preceding the diagnosed disease. Based on this model, the question arises how case-finding can be assessed in the…
Using excess deaths and testing statistics to improve estimates of COVID-19 mortalities
Factors such as non-uniform definitions of mortality, uncertainty in disease prevalence, and biased sampling complicate the quantification of fatality during an epidemic. Regardless of the employed fatality measure, the …
Estimation of age-specific excess mortality of men and women with rheumatoid arthritis (RA) in Germany
A MCMC approach is used to estimate the age-specific mortality rate ratio for German men and women with RA. For constructing priors, we calculate a range of admissible values from prevalence and incidence data based on a…